Logo image of LEN.B

LENNAR CORP - B SHS (LEN.B) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:LEN.B - US5260573028 - Common Stock

109.73 USD
-1.4 (-1.26%)
Last: 1/14/2026, 8:04:00 PM
109.73 USD
0 (0%)
After Hours: 1/14/2026, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to LEN.B. LEN.B was compared to 60 industry peers in the Household Durables industry. LEN.B has an average financial health and profitability rating. LEN.B is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • LEN.B had positive earnings in the past year.
  • In the past year LEN.B has reported a negative cash flow from operations.
  • Each year in the past 5 years LEN.B has been profitable.
  • LEN.B had a positive operating cash flow in 4 of the past 5 years.
LEN.B Yearly Net Income VS EBIT VS OCF VS FCFLEN.B Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • LEN.B has a better Return On Assets (7.62%) than 71.67% of its industry peers.
  • With a Return On Equity value of 11.77%, LEN.B perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
  • LEN.B has a better Return On Invested Capital (8.53%) than 63.33% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LEN.B is in line with the industry average of 9.73%.
Industry RankSector Rank
ROA 7.62%
ROE 11.77%
ROIC 8.53%
ROA(3y)10.3%
ROA(5y)11.22%
ROE(3y)15.58%
ROE(5y)17.34%
ROIC(3y)10.18%
ROIC(5y)11.88%
LEN.B Yearly ROA, ROE, ROICLEN.B Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • LEN.B's Profit Margin of 7.64% is fine compared to the rest of the industry. LEN.B outperforms 66.67% of its industry peers.
  • LEN.B's Profit Margin has been stable in the last couple of years.
  • With a decent Operating Margin value of 10.61%, LEN.B is doing good in the industry, outperforming 70.00% of the companies in the same industry.
  • LEN.B's Operating Margin has declined in the last couple of years.
  • The Gross Margin of LEN.B (12.38%) is worse than 91.67% of its industry peers.
  • In the last couple of years the Gross Margin of LEN.B has remained more or less at the same level.
Industry RankSector Rank
OM 10.61%
PM (TTM) 7.64%
GM 12.38%
OM growth 3Y-22.67%
OM growth 5Y-8.83%
PM growth 3Y-4.93%
PM growth 5Y1.45%
GM growth 3Y-7.29%
GM growth 5Y0.84%
LEN.B Yearly Profit, Operating, Gross MarginsLEN.B Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LEN.B is creating some value.
  • LEN.B has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, LEN.B has less shares outstanding
  • Compared to 1 year ago, LEN.B has a worse debt to assets ratio.
LEN.B Yearly Shares OutstandingLEN.B Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
LEN.B Yearly Total Debt VS Total AssetsLEN.B Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 4.12 indicates that LEN.B is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.12, LEN.B is doing good in the industry, outperforming 65.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.24 indicates that LEN.B is not too dependend on debt financing.
  • The Debt to Equity ratio of LEN.B (0.24) is better than 61.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 4.12
ROIC/WACC1
WACC8.55%
LEN.B Yearly LT Debt VS Equity VS FCFLEN.B Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • LEN.B has a Current Ratio of 9.39. This indicates that LEN.B is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of LEN.B (9.39) is better than 93.33% of its industry peers.
  • A Quick Ratio of 1.76 indicates that LEN.B should not have too much problems paying its short term obligations.
  • LEN.B has a better Quick ratio (1.76) than 78.33% of its industry peers.
Industry RankSector Rank
Current Ratio 9.39
Quick Ratio 1.76
LEN.B Yearly Current Assets VS Current LiabilitesLEN.B Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

  • The earnings per share for LEN.B have decreased strongly by -44.28% in the last year.
  • The Earnings Per Share has been growing slightly by 0.33% on average over the past years.
  • LEN.B shows a decrease in Revenue. In the last year, the revenue decreased by -3.54%.
  • Measured over the past years, LEN.B shows a quite strong growth in Revenue. The Revenue has been growing by 8.74% on average per year.
EPS 1Y (TTM)-44.28%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.46%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-5.82%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, LEN.B will show a small growth in Revenue. The Revenue will grow by 7.26% on average per year.
EPS Next Y-3.89%
EPS Next 2Y9.36%
EPS Next 3Y16.99%
EPS Next 5Y25.99%
Revenue Next Year0.43%
Revenue Next 2Y-0.66%
Revenue Next 3Y4.69%
Revenue Next 5Y7.26%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
LEN.B Yearly Revenue VS EstimatesLEN.B Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
LEN.B Yearly EPS VS EstimatesLEN.B Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20 25

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 13.73 indicates a correct valuation of LEN.B.
  • Compared to the rest of the industry, the Price/Earnings ratio of LEN.B is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 27.33, LEN.B is valued a bit cheaper.
  • LEN.B is valuated correctly with a Price/Forward Earnings ratio of 14.29.
  • LEN.B's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.12, LEN.B is valued a bit cheaper.
Industry RankSector Rank
PE 13.73
Fwd PE 14.29
LEN.B Price Earnings VS Forward Price EarningsLEN.B Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • LEN.B's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.3
LEN.B Per share dataLEN.B EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • LEN.B's earnings are expected to grow with 16.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)41.79
EPS Next 2Y9.36%
EPS Next 3Y16.99%

6

5. Dividend

5.1 Amount

  • LEN.B has a Yearly Dividend Yield of 1.83%.
  • LEN.B's Dividend Yield is a higher than the industry average which is at 1.19.
  • Compared to an average S&P500 Dividend Yield of 1.91, LEN.B has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.83%

5.2 History

  • The dividend of LEN.B is nicely growing with an annual growth rate of 65.54%!
  • LEN.B has paid a dividend for at least 10 years, which is a reliable track record.
  • LEN.B has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)65.54%
Div Incr Years1
Div Non Decr Years15
LEN.B Yearly Dividends per shareLEN.B Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • LEN.B pays out 19.91% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of LEN.B is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP19.91%
EPS Next 2Y9.36%
EPS Next 3Y16.99%
LEN.B Yearly Income VS Free CF VS DividendLEN.B Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
LEN.B Dividend Payout.LEN.B Dividend Payout, showing the Payout Ratio.LEN.B Dividend Payout.PayoutRetained Earnings

LENNAR CORP - B SHS

NYSE:LEN.B (1/14/2026, 8:04:00 PM)

After market: 109.73 0 (0%)

109.73

-1.4 (-1.26%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)12-16
Earnings (Next)03-18
Inst Owners96.66%
Inst Owner Change-0.05%
Ins Owners1.22%
Ins Owner ChangeN/A
Market Cap27.98B
Revenue(TTM)34.19B
Net Income(TTM)2.66B
Analysts54.81
Price Target107.63 (-1.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.83%
Yearly Dividend2
Dividend Growth(5Y)65.54%
DP19.91%
Div Incr Years1
Div Non Decr Years15
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.1%
Min EPS beat(2)-7.71%
Max EPS beat(2)7.91%
EPS beat(4)2
Avg EPS beat(4)2.19%
Min EPS beat(4)-7.71%
Max EPS beat(4)11.86%
EPS beat(8)6
Avg EPS beat(8)6.21%
EPS beat(12)9
Avg EPS beat(12)9.23%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-3.05%
Max Revenue beat(2)1.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-3.05%
Max Revenue beat(4)1.66%
Revenue beat(8)5
Avg Revenue beat(8)0.71%
Revenue beat(12)8
Avg Revenue beat(12)2.24%
Revenue beat(16)11
Avg Revenue beat(16)1.82%
PT rev (1m)-11.61%
PT rev (3m)-15.91%
EPS NQ rev (1m)-0.32%
EPS NQ rev (3m)-2.12%
EPS NY rev (1m)-14.56%
EPS NY rev (3m)-19.78%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-0.5%
Revenue NY rev (1m)-2.68%
Revenue NY rev (3m)-2.95%
Valuation
Industry RankSector Rank
PE 13.73
Fwd PE 14.29
P/S 0.8
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB 1.48
EV/EBITDA 8.3
EPS(TTM)7.99
EY7.28%
EPS(NY)7.68
Fwd EY7%
FCF(TTM)-2.8
FCFYN/A
OCF(TTM)-2.23
OCFYN/A
SpS136.33
BVpS88.5
TBVpS74.26
PEG (NY)N/A
PEG (5Y)41.79
Graham Number126.14
Profitability
Industry RankSector Rank
ROA 7.62%
ROE 11.77%
ROCE 11.15%
ROIC 8.53%
ROICexc 8.99%
ROICexgc 14.18%
OM 10.61%
PM (TTM) 7.64%
GM 12.38%
FCFM N/A
ROA(3y)10.3%
ROA(5y)11.22%
ROE(3y)15.58%
ROE(5y)17.34%
ROIC(3y)10.18%
ROIC(5y)11.88%
ROICexc(3y)11.92%
ROICexc(5y)13.71%
ROICexgc(3y)18.83%
ROICexgc(5y)18.96%
ROCE(3y)13.3%
ROCE(5y)15.53%
ROICexgc growth 3Y-1.59%
ROICexgc growth 5Y11.09%
ROICexc growth 3Y-22.05%
ROICexc growth 5Y-3.19%
OM growth 3Y-22.67%
OM growth 5Y-8.83%
PM growth 3Y-4.93%
PM growth 5Y1.45%
GM growth 3Y-7.29%
GM growth 5Y0.84%
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 1.41
Cap/Depr 111.6%
Cap/Sales 0.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.39
Quick Ratio 1.76
Altman-Z 4.12
F-Score4
WACC8.55%
ROIC/WACC1
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.28%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.46%
EPS Next Y-3.89%
EPS Next 2Y9.36%
EPS Next 3Y16.99%
EPS Next 5Y25.99%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-5.82%
Revenue Next Year0.43%
Revenue Next 2Y-0.66%
Revenue Next 3Y4.69%
Revenue Next 5Y7.26%
EBIT growth 1Y-34.32%
EBIT growth 3Y-22.28%
EBIT growth 5Y-0.86%
EBIT Next Year-17.91%
EBIT Next 3Y12.63%
EBIT Next 5Y18.06%
FCF growth 1Y-118.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.14%
OCF growth 3YN/A
OCF growth 5YN/A

LENNAR CORP - B SHS / LEN.B FAQ

What is the fundamental rating for LEN.B stock?

ChartMill assigns a fundamental rating of 5 / 10 to LEN.B.


What is the valuation status for LEN.B stock?

ChartMill assigns a valuation rating of 3 / 10 to LENNAR CORP - B SHS (LEN.B). This can be considered as Overvalued.


Can you provide the profitability details for LENNAR CORP - B SHS?

LENNAR CORP - B SHS (LEN.B) has a profitability rating of 5 / 10.


Can you provide the financial health for LEN.B stock?

The financial health rating of LENNAR CORP - B SHS (LEN.B) is 6 / 10.


How sustainable is the dividend of LENNAR CORP - B SHS (LEN.B) stock?

The dividend rating of LENNAR CORP - B SHS (LEN.B) is 6 / 10 and the dividend payout ratio is 19.91%.